𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advanced non-small-cell lung cancer: adjunctive interferon γ in induction and maintenance therapy

✍ Scribed by C. Prior; S. Oroszy; W. Oberaigner; G. Ambrosch; A. Mohn-Staudner; W. Pfeifer; R. Pirker; H. Huber


Publisher
Springer-Verlag
Year
1999
Tongue
English
Weight
93 KB
Volume
125
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Recent advances in etoposide therapy for
✍ Philip Bonomi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of

Treatment of small cell lung cancer: Int
✍ Bezwoda, W. R. ;Derman, D. P. ;de Moor, N. G. ;Kallenbach, J. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract Forty‐eight patients with small cell lung cancer were treated with an intensive therapy regimen which included induction chemotherapy with vincristine, adriamycin, procarbazine, and methotrexate. This was followed by radiation therapy given to areas of residual disease after restaging.

Simultaneous chemoradiation in advanced
✍ Julianna Pisch; Stephen Malamud; James Harvey; Edward J. Beattie 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag

Incorporation of photodynamic therapy as
✍ Patrick Ross Jr.; John Grecula; Tanios Bekaii-Saab; Miguel Villalona-Calero; Gre 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Background and objectives: Incorporation of photodynamic therapy (pdt) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (nsclc) is explored. ## Study design/materials and methods: We present a retrospective review of 41